Ok, I'm a business news kinda guy. My undergrad degree is finance; I was a banker (I apologize for what I did to the American Economy, it was clearly all my fault, I'm sorry.)
Interestingly this week a number of earnings calls (aka where businesses talk about their results to analysts each quarter) Artificial Pancreas was a topic:
Here's a few I just posted about:
Tandem
Podd
Dexcom
Home Grown & Startup
Then there is Medtronic's latest not-in-the-USA-yet launch.
What I find interesting as a finance geek is the shift in tone from a kinda distant, "Hey this is some research someplace," to wall street asking, "Yo. Where's da product? And how'z youz gonna get a cut?" (Yes - analyst are James Cagney in some shoot 'em up film)
In my twisted mind, this is a significant sign of progress.
Keep it coming.
AP will come incrementally. These all suggest incremental steps. Like diabetes care perfection shouldn't be the Public Enemy of the good.
Interestingly this week a number of earnings calls (aka where businesses talk about their results to analysts each quarter) Artificial Pancreas was a topic:
Here's a few I just posted about:
Tandem
Podd
Dexcom
Home Grown & Startup
Then there is Medtronic's latest not-in-the-USA-yet launch.
What I find interesting as a finance geek is the shift in tone from a kinda distant, "Hey this is some research someplace," to wall street asking, "Yo. Where's da product? And how'z youz gonna get a cut?" (Yes - analyst are James Cagney in some shoot 'em up film)
In my twisted mind, this is a significant sign of progress.
Keep it coming.
AP will come incrementally. These all suggest incremental steps. Like diabetes care perfection shouldn't be the Public Enemy of the good.
Posts
Finance Watch is a public interest association dedicated to making finance work for the good of society. Milton Barbarosh
ReplyDelete